Trevi Therapeutics Inc (NASDAQ:TRVI) Stock Rockets 25% After The News

October 12, 2021

Trevi Therapeutics Inc. (NASDAQ: TRVI) jumped 25% as investors reacted positively to the company’s SEC filing. According to the SEC filing, Trevi Therapeutics has applied for a Registration Statement withdrawal that was initially filed with the US SEC on August 27, 2021. The company had filed the statement in connection with its proposed public offering for its ordinary shares, par value $0.001 per share. However, Trevi Therapeutics has decided not…

Read More >>

Trevi Therapeutics Inc (NASDAQ:TRVI) Stock Sees Buying Interest At 52-Week Low

October 11, 2021

Clinical stage biopharmaceutical company Trevi Therapeutics Inc (NASDAQ:TRVI) could be the stock to track this morning considering the fact that it has made a big move in the premarket trading period and gone up by as much as 32%. In this regard, it should be point out that the action in the stock is possibly related to an announcement that had been made by the company back on October 7….

Read More >>